Insider Transactions in Q4 2024 at Xenon Pharmaceuticals Inc. (XENE)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 18
2024
|
Sherry Aulin Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
18,709
-100.0%
|
$767,069
$41.21 P/Share
|
|
Dec 18
2024
|
Sherry Aulin Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,625
-25.47%
|
$271,625
$41.28 P/Share
|
|
Dec 18
2024
|
Sherry Aulin Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,334
+50.0%
|
$253,340
$10.51 P/Share
|
|
Nov 22
2024
|
Gary Patou |
SELL
Open market or private sale
|
Direct |
4,891
-9.38%
|
$200,531
$41.08 P/Share
|
|
Nov 22
2024
|
Gary Patou |
SELL
Payment of exercise price or tax liability
|
Direct |
1,695
-3.16%
|
$66,105
$39.8 P/Share
|
|
Nov 22
2024
|
Gary Patou |
BUY
Exercise of conversion of derivative security
|
Direct |
6,586
+10.91%
|
$65,860
$10.43 P/Share
|